Partnership with Sunshine Healthcare aims to build local pharmaceutical capabilities and strengthen supply chain resilience
Phase 1 study to evaluate Siglec-6-targeted CAR-T therapy in relapsed or refractory AML and CLL patients, marking a major milestone for T-CURX’s scalable non-viral CAR-T platform
Approval is based on results from the phase 3 OASIS 4 clinical trial
Approval strengthens the company’s growing international anti-infective portfolio
The US regulator conducted an inspection at the Amaliya manufacturing plant between April 20 and May 1, 2026
Company confirms seized products were not from its authorised supply chain and urges patients to purchase medicines only through licensed pharmacies
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
Neupharma gains exclusive rights to develop and commercialize corticorelin for peritumoral brain edema
If approved, TEV-'749 could help address a significant unmet need in available schizophrenia treatment options by addressing the lack of viable long-acting olanzapine formulations
Venglustat, a glucosylceramide synthase inhibitor (GCSi), works by reducing the abnormal buildup of sugar-and-fat molecules in cells and organs
Subscribe To Our Newsletter & Stay Updated
